August

RefinedScience Helps CU Anschutz Researchers Unlock Insights by Bridging Biology and Clinical Data

Hematology Researchers Identify an 'Energy Addiction' in High-Risk Blood Cancer Stem Cells

June

A new study led by CU Anschutz Cancer Center member Ajay Major, MD, MBA, surveyed patients with relapsed lymphoma about the time burdens of treatments

Leading the Charge in Acute Myeloid Leukemia: new treatments and new hope for patients - and the work continues

Nurses throw surprise graduation for Colorado School of Mines senior diagnosed with cancer

December 2025

Rewriting the Rulebook of Blood: Eric Pietras, PhD shared insights that could reshape how we think about aging and cancer risk at 2025 American Society of Hematology

November 2025

Mathew Angelos, MD, PhD tests a "Homegrown Treatment," a novel chimeric antigen receptor (CAR) T-cell therapy for an aggressive, difficult to treat leukemia.

September 2025

Ron Uecker's B-cell lymphoma got under control in the clinical trial overseen by Manali Kamdar, MD. The trial combines a targeted chemotherapy treatment with a bispecific antibody.

August 2025

Lymphoma expert, Manali Kamdar, MD, sees a 'Huge Win for Patients' when barriers for CAR T-Cell treatment are lowered. FDA rule change lowers barriers.

June 2025

Eric Pietras, PhD and Brett Stevens, PhD team up on a multi-year search for better ways to target the malignant blood-forming stem cells that give rise to a spectrum of blood cancers called myelodysplastic syndrome (MDS).

May 2025

Hematology's Steve Bair, MD, a lymphoma expert, weighs in on alarming recent research suggesting an increased cancer risk among people with tattoos.

January 2025

Hematology's Jonathan Gutman, MD, a member of the CU Department of Medicine's  Clinical Excellence Society specializes in stem cell transplants for leukemia and other blood cancer patients.

Daniel Pollyea, MD, MS Recognized by the Leukemia & Lymphoma Society for His Research on Leukemia Stem Cells